数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
David King 男 Chair of the Board and Independent Director 70 34.48万美元 3.39 2026-03-23
Shawn Morris 男 Director 62 27.48万美元 463.91 2026-03-23
Thomas McCarthy 男 Independent Director 69 29.98万美元 5.26 2026-03-23
Parth Mehrotra 男 Chief Executive Officer and Director 47 1047.27万美元 68.59 2026-03-23
Jaewon Ryu 男 Independent Director 52 27.63万美元 3.03 2026-03-23
Lance Berberian 男 Independent Director 63 17.39万美元 未持股 2026-03-23
Pamela Kimmet 女 Independent Director 67 29.48万美元 1.73 2026-03-23
Nancy Cocozza 女 Independent Director 65 27.48万美元 2.60 2026-03-23
Jaewon Ryu 男 Independent Director 52 未披露 未持股 2026-03-23
Francis Soistman 男 Director 69 未披露 未持股 2026-03-23

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Parth Mehrotra 男 Chief Executive Officer and Director 47 1047.27万美元 68.59 2026-03-23
David Mountcastle 男 Chief Financial Officer and Executive Vice President 56 302.06万美元 33.23 2026-03-23
Edward C. Fargis 男 Executive Vice President and General Counsel 61 235.74万美元 2.24 2026-03-23

董事简历

中英对照 |  中文 |  英文
David King

David King于2017年8月成为我们的董事会成员,并自2017年5月起担任Preferred Proppants的董事会成员。King先生目前担任Sheridan Production Company,LLC的投资委员会成员。投资委员会监督投资决策和战略规划。此前,King先生曾担任Seventy Seven Energy,Inc.的董事兼薪酬与治理委员会主席。在32年的职业生涯后于2010年4月退休之前,King先生在哈里伯顿(Halliburton)担任完井和生产部总裁,在那里他负责维持泵送服务和完井工具的行业领导地位。他曾担任公司的执行委员会成员,并担任公司的首席健康、安全和环境官。他于2013年加入Archer,Ltd.,在那里他曾担任上市全球服务公司的首席执行官(直到2016年)。King先生拥有阿拉巴马大学(University of Alabama)的工程学士学位,在那里他于2007年被认可为工程学院(College of Engineering)杰出院士。


David King has been the Managing Member of KingMan LLC, a provider of strategic consulting services for stakeholders across the healthcare system, since December 2021. Prior to this role, Mr. King served as an Operating Partner at Pritzker Private Capital from August 2020 to December 2021, co leading the firm's activities in the healthcare sector. Prior to joining Pritzker Private Capital, Mr. King was the Chief Executive Officer of Laboratory Corporation of America Holdings (NYSE: LH) from 2007 to 2019. At Laboratory Corporation of America Holdings, Mr. King also served as the Executive Chair of the Board from November 2019 to May 2020, and as the Non Executive Chair of the Board from May 2009 to October 2019. Mr. King served as a director of ZimVie, Inc. (Nasdaq: ZIMV) from 2022 to 2025 and is a member of the board of several private companies. Mr. King also currently serves on the Board of Smith & Nephew, plc (LSE: SN and NYSE: SNN) and the board of trustees of Novant Health. Mr. King previously served on the board of Cardinal Health (NYSE: CAH), PATH (where he completed four years as Chair in December 2021), the Advisory Board for Duke University's Robert J. Margolis, MD, Center for Health Policy (where he served from 2017 to 2025), and the American Clinical Laboratory Association (where he served as Chair from 2010 to 2014). Mr. King also served on the board of The Emily K Center, a college readiness center in Durham, North Carolina, founded by Mike Krzyzewski, the former head coach of the Duke University Men's Basketball team. Mr. King received a bachelor's degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.
David King于2017年8月成为我们的董事会成员,并自2017年5月起担任Preferred Proppants的董事会成员。King先生目前担任Sheridan Production Company,LLC的投资委员会成员。投资委员会监督投资决策和战略规划。此前,King先生曾担任Seventy Seven Energy,Inc.的董事兼薪酬与治理委员会主席。在32年的职业生涯后于2010年4月退休之前,King先生在哈里伯顿(Halliburton)担任完井和生产部总裁,在那里他负责维持泵送服务和完井工具的行业领导地位。他曾担任公司的执行委员会成员,并担任公司的首席健康、安全和环境官。他于2013年加入Archer,Ltd.,在那里他曾担任上市全球服务公司的首席执行官(直到2016年)。King先生拥有阿拉巴马大学(University of Alabama)的工程学士学位,在那里他于2007年被认可为工程学院(College of Engineering)杰出院士。
David King has been the Managing Member of KingMan LLC, a provider of strategic consulting services for stakeholders across the healthcare system, since December 2021. Prior to this role, Mr. King served as an Operating Partner at Pritzker Private Capital from August 2020 to December 2021, co leading the firm's activities in the healthcare sector. Prior to joining Pritzker Private Capital, Mr. King was the Chief Executive Officer of Laboratory Corporation of America Holdings (NYSE: LH) from 2007 to 2019. At Laboratory Corporation of America Holdings, Mr. King also served as the Executive Chair of the Board from November 2019 to May 2020, and as the Non Executive Chair of the Board from May 2009 to October 2019. Mr. King served as a director of ZimVie, Inc. (Nasdaq: ZIMV) from 2022 to 2025 and is a member of the board of several private companies. Mr. King also currently serves on the Board of Smith & Nephew, plc (LSE: SN and NYSE: SNN) and the board of trustees of Novant Health. Mr. King previously served on the board of Cardinal Health (NYSE: CAH), PATH (where he completed four years as Chair in December 2021), the Advisory Board for Duke University's Robert J. Margolis, MD, Center for Health Policy (where he served from 2017 to 2025), and the American Clinical Laboratory Association (where he served as Chair from 2010 to 2014). Mr. King also served on the board of The Emily K Center, a college readiness center in Durham, North Carolina, founded by Mike Krzyzewski, the former head coach of the Duke University Men's Basketball team. Mr. King received a bachelor's degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.
Shawn Morris

Shawn Morris自2018年5月起担任我们的首席执行官兼董事会成员。在Privia Health任职之前,莫里斯先生于2016年至2018年担任信诺公司Cigna-HealthSpring的总裁。在2016年之前,从2010年开始,莫里斯先生在Cigna-HealthSpring担任过各种领导职务,包括首席运营官,开发与创新总裁以及执行Vice President。Morris先生在西肯塔基大学(Western Kentucky University)获得会计学B.S.,是一名注册会计师。莫里斯先生也是达特茅斯学院塔克商学院2030全球执行项目的毕业生,纳什维尔梦百合委员会的创始研究员,美国注册会计师协会,全国公司董事协会和美国医学协会首席执行官咨询委员会的成员。


Shawn Morris is Privia Health Group, Inc.'s former Chief Executive Officer and has served as a member of Privia Health Group, Inc.'s board of directors since May 2018. Prior to his role at Privia Health, Mr. Morris was a leader at Cigna HealthSpring, a Cigna company, known previously as HealthSpring, from 2005 to 2018. Mr. Morris held various leadership roles at Cigna HealthSpring, including the positions of President, Chief Operating Officer, President of Development & Innovation, and Executive Vice President. Mr. Morris also serves on the board of Mainstreet Health, a private company headquartered in Nashville, Tennessee. Mr. Morris received a bachelor's degree in Accounting from the Western Kentucky University and is a Certified Public Accountant (inactive). Mr. Morris is also a graduate of Dartmouth College's Tuck Business School 2030 Global Executive program and an inaugural Fellow of the Nashville Healthcare Council.
Shawn Morris自2018年5月起担任我们的首席执行官兼董事会成员。在Privia Health任职之前,莫里斯先生于2016年至2018年担任信诺公司Cigna-HealthSpring的总裁。在2016年之前,从2010年开始,莫里斯先生在Cigna-HealthSpring担任过各种领导职务,包括首席运营官,开发与创新总裁以及执行Vice President。Morris先生在西肯塔基大学(Western Kentucky University)获得会计学B.S.,是一名注册会计师。莫里斯先生也是达特茅斯学院塔克商学院2030全球执行项目的毕业生,纳什维尔梦百合委员会的创始研究员,美国注册会计师协会,全国公司董事协会和美国医学协会首席执行官咨询委员会的成员。
Shawn Morris is Privia Health Group, Inc.'s former Chief Executive Officer and has served as a member of Privia Health Group, Inc.'s board of directors since May 2018. Prior to his role at Privia Health, Mr. Morris was a leader at Cigna HealthSpring, a Cigna company, known previously as HealthSpring, from 2005 to 2018. Mr. Morris held various leadership roles at Cigna HealthSpring, including the positions of President, Chief Operating Officer, President of Development & Innovation, and Executive Vice President. Mr. Morris also serves on the board of Mainstreet Health, a private company headquartered in Nashville, Tennessee. Mr. Morris received a bachelor's degree in Accounting from the Western Kentucky University and is a Certified Public Accountant (inactive). Mr. Morris is also a graduate of Dartmouth College's Tuck Business School 2030 Global Executive program and an inaugural Fellow of the Nashville Healthcare Council.
Thomas McCarthy

托马斯·麦卡锡在梦百合、保险和金融服务业务方面拥有超过35年的经验,包括在信诺保险集团公司(纽约证券交易所代码:CI)超过30年的经验。麦卡锡先生最近于2013年7月至2017年6月担任信诺执行Vice President兼首席财务官,此前曾于2003年3月至2013年7月担任信诺财务Vice President,Vice President兼财务主管,战略与企业发展Vice President。除了在Cigna的职业生涯外,McCarthy先生还于1999年7月至2003年2月在Kemper Insurance和1985年至1986年在USAA担任高级领导职务。McCarthy先生是Selective InsuranceGroup,Inc.(纳斯达克市场代码:SIGI)的董事会成员,该公司是一家总部位于新泽西州的财产和意外保险公司的控股公司,也是审计和财务委员会的成员。他也是the American University of Rome的董事会成员,以及the Habitat for Humanity of Montgomery and Delaware Counties的董事。McCarthy先生在宾夕法尼亚大学沃顿商学院(Wharton School of the University of Pennsylvania)获得金融学学士学位,并在卡内基梅隆大学(Carnegie Mellon University)泰珀商学院(Tepper School of Business)获得工商管理硕士学位。


Thomas McCarthy has over 35 years of experience in healthcare, insurance and financial services businesses, including more than 30 years with Cigna Corporation (NYSE: CI). Mr. McCarthy was most recently the Executive Vice President and Chief Financial Officer at Cigna from July 2013 to June 2017, and previously held the roles of Vice President of Finance, Vice President & Treasurer, Vice President of Strategy and Corporate Development between March 2003 to July 2013. In addition to his career with Cigna, Mr. McCarthy also held senior leadership roles at Kemper Insurance from July 1999 to February 2003 and USAA from 1985 to 1986. Mr. McCarthy is a member of the board of directors of Selective Insurance Group, Inc. (Nasdaq: SIGI), a New Jersey based holding company for property and casualty insurance companies, and is a member of the Selective Insurance Audit Committee and Finance and Investments Committee. He is also a member of the Board of Trustees of the American University of Rome and a Director of Avenue of the Arts, Inc. He previously served as a Director of the Habitat for Humanity of Montgomery and Delaware Counties from 2017 to 2024. Mr. McCarthy received a bachelor's degree in Finance from the Wharton School of the University of Pennsylvania and an MBA from Carnegie Mellon University's Tepper School of Business.
托马斯·麦卡锡在梦百合、保险和金融服务业务方面拥有超过35年的经验,包括在信诺保险集团公司(纽约证券交易所代码:CI)超过30年的经验。麦卡锡先生最近于2013年7月至2017年6月担任信诺执行Vice President兼首席财务官,此前曾于2003年3月至2013年7月担任信诺财务Vice President,Vice President兼财务主管,战略与企业发展Vice President。除了在Cigna的职业生涯外,McCarthy先生还于1999年7月至2003年2月在Kemper Insurance和1985年至1986年在USAA担任高级领导职务。McCarthy先生是Selective InsuranceGroup,Inc.(纳斯达克市场代码:SIGI)的董事会成员,该公司是一家总部位于新泽西州的财产和意外保险公司的控股公司,也是审计和财务委员会的成员。他也是the American University of Rome的董事会成员,以及the Habitat for Humanity of Montgomery and Delaware Counties的董事。McCarthy先生在宾夕法尼亚大学沃顿商学院(Wharton School of the University of Pennsylvania)获得金融学学士学位,并在卡内基梅隆大学(Carnegie Mellon University)泰珀商学院(Tepper School of Business)获得工商管理硕士学位。
Thomas McCarthy has over 35 years of experience in healthcare, insurance and financial services businesses, including more than 30 years with Cigna Corporation (NYSE: CI). Mr. McCarthy was most recently the Executive Vice President and Chief Financial Officer at Cigna from July 2013 to June 2017, and previously held the roles of Vice President of Finance, Vice President & Treasurer, Vice President of Strategy and Corporate Development between March 2003 to July 2013. In addition to his career with Cigna, Mr. McCarthy also held senior leadership roles at Kemper Insurance from July 1999 to February 2003 and USAA from 1985 to 1986. Mr. McCarthy is a member of the board of directors of Selective Insurance Group, Inc. (Nasdaq: SIGI), a New Jersey based holding company for property and casualty insurance companies, and is a member of the Selective Insurance Audit Committee and Finance and Investments Committee. He is also a member of the Board of Trustees of the American University of Rome and a Director of Avenue of the Arts, Inc. He previously served as a Director of the Habitat for Humanity of Montgomery and Delaware Counties from 2017 to 2024. Mr. McCarthy received a bachelor's degree in Finance from the Wharton School of the University of Pennsylvania and an MBA from Carnegie Mellon University's Tepper School of Business.
Parth Mehrotra

Parth Mehrotra自2018年以来一直担任我们的总裁兼首席运营官。在Privia Health任职之前,Mehrotra先生于2016年至2018年担任Privia Health母公司Brighton Health Group Holdings,LLC的首席运营官。2016年之前,Mehrotra先生曾在AthenaHealth Inc.担任高级财务职位,也曾在高盛(Goldman Sachs and Co.)的梦百合投资银行集团工作,并担任埃森哲(Accenture)的管理顾问。Mehrotra先生在西北大学凯洛格管理学院(Northwestern University&8217;s Kellogg School of Management)获得工商管理硕士学位,并在德里大学圣斯蒂芬学院(St.Stephen&8217;s College)获得经济学学士学位。


Parth Mehrotra has served as the Chief Executive Officer of Privia Health since July 2023. Prior to that, he served as Privia Health Group, Inc.'s President and Chief Operating Officer from 2018 to 2023. Prior to his role at Privia Health, from 2016 to 2018, Mr. Mehrotra was the Chief Operating Officer of Brighton Health Group Holdings, LLC, the parent company of Privia Health. Prior to 2016, Mr. Mehrotra held a senior finance role at athenahealth Inc., and also worked in the healthcare investment banking group at Goldman Sachs and Co. and as a management consultant at Accenture. Mr. Mehrotra received an M.B.A. from Northwestern University's Kellogg School of Management and a bachelor's degree in Economics from St. Stephen's College, University of Delhi.
Parth Mehrotra自2018年以来一直担任我们的总裁兼首席运营官。在Privia Health任职之前,Mehrotra先生于2016年至2018年担任Privia Health母公司Brighton Health Group Holdings,LLC的首席运营官。2016年之前,Mehrotra先生曾在AthenaHealth Inc.担任高级财务职位,也曾在高盛(Goldman Sachs and Co.)的梦百合投资银行集团工作,并担任埃森哲(Accenture)的管理顾问。Mehrotra先生在西北大学凯洛格管理学院(Northwestern University&8217;s Kellogg School of Management)获得工商管理硕士学位,并在德里大学圣斯蒂芬学院(St.Stephen&8217;s College)获得经济学学士学位。
Parth Mehrotra has served as the Chief Executive Officer of Privia Health since July 2023. Prior to that, he served as Privia Health Group, Inc.'s President and Chief Operating Officer from 2018 to 2023. Prior to his role at Privia Health, from 2016 to 2018, Mr. Mehrotra was the Chief Operating Officer of Brighton Health Group Holdings, LLC, the parent company of Privia Health. Prior to 2016, Mr. Mehrotra held a senior finance role at athenahealth Inc., and also worked in the healthcare investment banking group at Goldman Sachs and Co. and as a management consultant at Accenture. Mr. Mehrotra received an M.B.A. from Northwestern University's Kellogg School of Management and a bachelor's degree in Economics from St. Stephen's College, University of Delhi.
Jaewon Ryu

Jaewon Ryu自2023年起担任泰利福的董事,目前担任薪酬委员会成员。自2024年4月以来,Ryu博士一直担任Risant Health的首席执行官,Risant Health是一家非营利性医疗保健组织,为其成员健康系统提供支持系统和服务。2019年6月至2024年4月,Ryu博士担任歌辛格健康的总裁兼首席执行官,该公司是一家集临床企业、健康计划、医学院和研创功能于一体的医疗保健系统。他于2016年10月加入盖辛格,担任执行副总裁兼首席医疗官至2018年12月。2018年12月至2019年6月,任歌辛格临时总裁兼首席执行官。在加入歌辛格之前,Ryu博士于2014年1月至2016年9月期间担任健康保险公司哈门那,公司的总裁,Integrated Care Delivery。在此之前,他曾在伊利诺伊大学医院和Health Sciences系统以及Kaiser Permanente担任过各种领导职务,此前曾担任企业医疗保健律师,并曾在医疗保险和医疗补助服务中心以及退伍军人事务部担任政府职务。Ryu博士现任Privia Health Group, Inc.董事


Jaewon Ryu has been a director of Teleflex since 2023 and currently serves as a member of the Compensation Committee. Since April 2024, Dr. Ryu has been the Chief Executive Officer of Risant Health, a nonprofit healthcare organization that provides support systems and services to its constituent health systems. From June 2019 to April 2024, Dr. Ryu served as the President and Chief Executive Officer of Geisinger Health, an integrated healthcare system with a clinical enterprise, health plan, a school of medicine and research and innovation functions. He joined Geisinger in October 2016 and served as Executive Vice President and Chief Medical Officer until December 2018. From December 2018 to June 2019, he served as Interim President and Chief Executive Officer of Geisinger. Prior to joining Geisinger, Dr. Ryu served as President, Integrated Care Delivery for Humana, Inc., a health insurance company, from January 2014 to September 2016. Previously, he served in various leadership capacities at the University of Illinois Hospital and Health Sciences System and Kaiser Permanente, after having practiced as a corporate healthcare attorney and worked in government roles at the Centers for Medicare and Medicaid Services and the Department of Veterans Affairs. Dr. Ryu is currently a director of Privia Health Group, Inc.
Jaewon Ryu自2023年起担任泰利福的董事,目前担任薪酬委员会成员。自2024年4月以来,Ryu博士一直担任Risant Health的首席执行官,Risant Health是一家非营利性医疗保健组织,为其成员健康系统提供支持系统和服务。2019年6月至2024年4月,Ryu博士担任歌辛格健康的总裁兼首席执行官,该公司是一家集临床企业、健康计划、医学院和研创功能于一体的医疗保健系统。他于2016年10月加入盖辛格,担任执行副总裁兼首席医疗官至2018年12月。2018年12月至2019年6月,任歌辛格临时总裁兼首席执行官。在加入歌辛格之前,Ryu博士于2014年1月至2016年9月期间担任健康保险公司哈门那,公司的总裁,Integrated Care Delivery。在此之前,他曾在伊利诺伊大学医院和Health Sciences系统以及Kaiser Permanente担任过各种领导职务,此前曾担任企业医疗保健律师,并曾在医疗保险和医疗补助服务中心以及退伍军人事务部担任政府职务。Ryu博士现任Privia Health Group, Inc.董事
Jaewon Ryu has been a director of Teleflex since 2023 and currently serves as a member of the Compensation Committee. Since April 2024, Dr. Ryu has been the Chief Executive Officer of Risant Health, a nonprofit healthcare organization that provides support systems and services to its constituent health systems. From June 2019 to April 2024, Dr. Ryu served as the President and Chief Executive Officer of Geisinger Health, an integrated healthcare system with a clinical enterprise, health plan, a school of medicine and research and innovation functions. He joined Geisinger in October 2016 and served as Executive Vice President and Chief Medical Officer until December 2018. From December 2018 to June 2019, he served as Interim President and Chief Executive Officer of Geisinger. Prior to joining Geisinger, Dr. Ryu served as President, Integrated Care Delivery for Humana, Inc., a health insurance company, from January 2014 to September 2016. Previously, he served in various leadership capacities at the University of Illinois Hospital and Health Sciences System and Kaiser Permanente, after having practiced as a corporate healthcare attorney and worked in government roles at the Centers for Medicare and Medicaid Services and the Department of Veterans Affairs. Dr. Ryu is currently a director of Privia Health Group, Inc.
Lance Berberian

Lance Berberian,曾在徕博科控股公司(NYSE:LH)担任执行副总裁兼首席信息和技术官,管理着一支5000人的团队,专注于IT战略、网络安全、人工智能、产品开发和数据管理。在加入徕博科之前,Berberian先生曾在爱德士、Kellstrom Aerospace、Interim HealthCare和Quest Diagnostics.Mr担任首席信息官。Berberian目前在埃隆大学董事会任职,此前曾担任NC State Computer Science战略顾问委员会主席。他拥有托马斯爱迪生州立学院工商管理和信息技术学士学位。


Lance Berberian is a technology strategist with over 30 years of experience in innovation and business growth, specializing in digital transformation and corporate governance. From 2014 to October 2024, he served as EVP and Chief Information and Technology Officer at Labcorp, overseeing a team of 5,000 people focused on IT strategy, cybersecurity, AI, product development, and data management to drive growth and enhance operational efficiencies in a major global life sciences company. From November 2024 until his retirement in early 2025, Mr. Berberian served as a Special Advisor, Strategy at Labcorp. Prior to Labcorp, he held CIO roles at IDEXX Laboratories, Kellstrom Aerospace, Interim HealthCare and Quest Diagnostics. Mr. Berberian's prior senior executive roles include serving as the President of the Kellstrom Defense Aerospace business unit and in other senior operational leadership roles for Kellstrom Industries' portfolio of data and technology businesses. He currently serves on the Elon University Board of Trustees and previously chaired the NC State Computer Science Strategic Advisory Board. He holds a BA in business administration and information technology from Thomas Edison State College and the CERT Certificate in Cybersecurity Oversight from the National Association of Corporate Directors and the Software Engineering Institute of Carnegie Mellon University.
Lance Berberian,曾在徕博科控股公司(NYSE:LH)担任执行副总裁兼首席信息和技术官,管理着一支5000人的团队,专注于IT战略、网络安全、人工智能、产品开发和数据管理。在加入徕博科之前,Berberian先生曾在爱德士、Kellstrom Aerospace、Interim HealthCare和Quest Diagnostics.Mr担任首席信息官。Berberian目前在埃隆大学董事会任职,此前曾担任NC State Computer Science战略顾问委员会主席。他拥有托马斯爱迪生州立学院工商管理和信息技术学士学位。
Lance Berberian is a technology strategist with over 30 years of experience in innovation and business growth, specializing in digital transformation and corporate governance. From 2014 to October 2024, he served as EVP and Chief Information and Technology Officer at Labcorp, overseeing a team of 5,000 people focused on IT strategy, cybersecurity, AI, product development, and data management to drive growth and enhance operational efficiencies in a major global life sciences company. From November 2024 until his retirement in early 2025, Mr. Berberian served as a Special Advisor, Strategy at Labcorp. Prior to Labcorp, he held CIO roles at IDEXX Laboratories, Kellstrom Aerospace, Interim HealthCare and Quest Diagnostics. Mr. Berberian's prior senior executive roles include serving as the President of the Kellstrom Defense Aerospace business unit and in other senior operational leadership roles for Kellstrom Industries' portfolio of data and technology businesses. He currently serves on the Elon University Board of Trustees and previously chaired the NC State Computer Science Strategic Advisory Board. He holds a BA in business administration and information technology from Thomas Edison State College and the CERT Certificate in Cybersecurity Oversight from the National Association of Corporate Directors and the Software Engineering Institute of Carnegie Mellon University.
Pamela Kimmet

Pamela Kimmet担任宏利金融有限公司(NYSE:MFC)首席人力资源官(CHRO)至2025年6月1日退休。在2018年10月加入宏利担任CHRO之前,Kimmet女士于2016年3月至2018年9月期间担任宏利董事会成员。Kimmet女士此前曾担任卡地纳健康集团(NYSE:CAH)、Coca Cola Enterprises,Inc.(现为Coca Cola Europacific Partners,纳斯达克:CCEP)、The Bear Stearns Companies,Inc.和Lucent Technologies的CHRO。她还曾在花旗集团和通用汽车担任过一系列人力资源战略职务。Kimmet女士此前曾在Perspecta,Inc.董事会任职,并担任其管理和薪酬委员会主席,直到2021年5月Veritas Capital收购该组织。Kimmet女士目前担任南卡罗来纳大学Darla Moore学院高管继任中心的执行顾问。此外,在她的职业生涯中,她一直是人力资源专业社区的活跃成员。她目前担任美国国家人力资源研究院董事会成员,此前曾担任CHRO协会董事会主席,并曾担任该协会高管薪酬中心的前任主席。她还担任国家卫生事业集团董事会主席。Kimmet女士拥有密歇根州立大学MBA学位和康奈尔大学工业与劳动关系学士学位。


Pamela Kimmet served as the chief human resources officer (CHRO) of Manulife Financial Corporation (NYSE: MFC) until her retirement on June 1, 2025. Prior to joining Manulife as CHRO in October 2018, Ms. Kimmet served on Manulife's Board of Directors from March 2016 through September 2018. Ms. Kimmet previously served as CHRO of Cardinal Health, Inc. (NYSE: CAH) and Coca Cola Enterprises, Inc. (now Coca Cola Europacific Partners, Nasdaq: CCEP), The Bear Stearns Companies, Inc. and Lucent Technologies. She also held a range of strategic HR roles at Citigroup and General Motors. Ms. Kimmet previously served on the Board of Directors of Perspecta, Inc. and chaired its Management and Compensation Committee until May 2021 when Veritas Capital acquired the organization. Ms. Kimmet currently serves as the Executive Advisor to the University of South Carolina's Darla Moore School's Center for Executive Succession. Additionally, over her career she has been an active member of the human resources professional community. She currently serves on the board of the National Academy of Human Resources and previously chaired the board of The CHRO Association, as well as being past chair of its Center for Executive Compensation. She also chaired the board of the National Business Group on Health. Ms. Kimmet holds an MBA from Michigan State University and a bachelor's degree in Industrial and Labor Relations from Cornell University.
Pamela Kimmet担任宏利金融有限公司(NYSE:MFC)首席人力资源官(CHRO)至2025年6月1日退休。在2018年10月加入宏利担任CHRO之前,Kimmet女士于2016年3月至2018年9月期间担任宏利董事会成员。Kimmet女士此前曾担任卡地纳健康集团(NYSE:CAH)、Coca Cola Enterprises,Inc.(现为Coca Cola Europacific Partners,纳斯达克:CCEP)、The Bear Stearns Companies,Inc.和Lucent Technologies的CHRO。她还曾在花旗集团和通用汽车担任过一系列人力资源战略职务。Kimmet女士此前曾在Perspecta,Inc.董事会任职,并担任其管理和薪酬委员会主席,直到2021年5月Veritas Capital收购该组织。Kimmet女士目前担任南卡罗来纳大学Darla Moore学院高管继任中心的执行顾问。此外,在她的职业生涯中,她一直是人力资源专业社区的活跃成员。她目前担任美国国家人力资源研究院董事会成员,此前曾担任CHRO协会董事会主席,并曾担任该协会高管薪酬中心的前任主席。她还担任国家卫生事业集团董事会主席。Kimmet女士拥有密歇根州立大学MBA学位和康奈尔大学工业与劳动关系学士学位。
Pamela Kimmet served as the chief human resources officer (CHRO) of Manulife Financial Corporation (NYSE: MFC) until her retirement on June 1, 2025. Prior to joining Manulife as CHRO in October 2018, Ms. Kimmet served on Manulife's Board of Directors from March 2016 through September 2018. Ms. Kimmet previously served as CHRO of Cardinal Health, Inc. (NYSE: CAH) and Coca Cola Enterprises, Inc. (now Coca Cola Europacific Partners, Nasdaq: CCEP), The Bear Stearns Companies, Inc. and Lucent Technologies. She also held a range of strategic HR roles at Citigroup and General Motors. Ms. Kimmet previously served on the Board of Directors of Perspecta, Inc. and chaired its Management and Compensation Committee until May 2021 when Veritas Capital acquired the organization. Ms. Kimmet currently serves as the Executive Advisor to the University of South Carolina's Darla Moore School's Center for Executive Succession. Additionally, over her career she has been an active member of the human resources professional community. She currently serves on the board of the National Academy of Human Resources and previously chaired the board of The CHRO Association, as well as being past chair of its Center for Executive Compensation. She also chaired the board of the National Business Group on Health. Ms. Kimmet holds an MBA from Michigan State University and a bachelor's degree in Industrial and Labor Relations from Cornell University.
Nancy Cocozza

Nancy Cocozza在医疗保健和政府项目方面拥有超过25年的经验。Cocozza女士于2018年6月从Aetna医疗保险业务总裁的职位上退休,负责Aetna的医疗保险战略、增长和运营结果。在加入安泰保险之前,Cocozza女士是个人市场健康保险提供商HealthMarkets的执行副总裁,在那里她领导了医疗保险部门。她还领导了考文垂保健的政府保险项目。Cocozza女士的职业生涯始于Aetna,在那里她花了16年时间建立并领导各种商业管理式医疗业务。Cocozza女士最近于2018年8月至2021年3月期间在Aspira Women's Health,Inc.(纳斯达克:AWH)的董事会任职,在其任职期间担任各审计、薪酬以及提名和治理委员会的成员。Cocozza女士获得了Thomas Jefferson/费城大学会计学学士学位。


Nancy Cocozza has over 25 years of experience in healthcare and government programs. Ms. Cocozza retired in June 2018 from the position of President of the Medicare Business for Aetna, where she was responsible for Aetna's Medicare strategy, growth and operating results. Prior to Aetna, Ms. Cocozza was Executive Vice President at HealthMarkets, an individual market health insurance provider, where she led the Medicare division. She also led the government insurance programs at Coventry Health Care. Ms. Cocozza began her career at Aetna, where she spent 16 years building and leading various commercial managed care operations. Ms. Cocozza most recently served on the Board of Directors of Aspira Women's Health, Inc. (Nasdaq: AWH) from August 2018 until March 2021, serving on each of its Audit, Compensation and Nominating and Governance committees during her tenure. Ms. Cocozza received a bachelor's degree in accounting from Thomas Jefferson/Philadelphia University.
Nancy Cocozza在医疗保健和政府项目方面拥有超过25年的经验。Cocozza女士于2018年6月从Aetna医疗保险业务总裁的职位上退休,负责Aetna的医疗保险战略、增长和运营结果。在加入安泰保险之前,Cocozza女士是个人市场健康保险提供商HealthMarkets的执行副总裁,在那里她领导了医疗保险部门。她还领导了考文垂保健的政府保险项目。Cocozza女士的职业生涯始于Aetna,在那里她花了16年时间建立并领导各种商业管理式医疗业务。Cocozza女士最近于2018年8月至2021年3月期间在Aspira Women's Health,Inc.(纳斯达克:AWH)的董事会任职,在其任职期间担任各审计、薪酬以及提名和治理委员会的成员。Cocozza女士获得了Thomas Jefferson/费城大学会计学学士学位。
Nancy Cocozza has over 25 years of experience in healthcare and government programs. Ms. Cocozza retired in June 2018 from the position of President of the Medicare Business for Aetna, where she was responsible for Aetna's Medicare strategy, growth and operating results. Prior to Aetna, Ms. Cocozza was Executive Vice President at HealthMarkets, an individual market health insurance provider, where she led the Medicare division. She also led the government insurance programs at Coventry Health Care. Ms. Cocozza began her career at Aetna, where she spent 16 years building and leading various commercial managed care operations. Ms. Cocozza most recently served on the Board of Directors of Aspira Women's Health, Inc. (Nasdaq: AWH) from August 2018 until March 2021, serving on each of its Audit, Compensation and Nominating and Governance committees during her tenure. Ms. Cocozza received a bachelor's degree in accounting from Thomas Jefferson/Philadelphia University.
Jaewon Ryu

自2024年4月收购Geisinger以来,Jaewon Ryu一直担任Risant Health的首席执行官。此前,他自2019年6月起担任Geisinger的总裁兼首席执行官,Geisinger是一家与临床企业、健康计划、Geisinger联邦医学院以及在宾夕法尼亚州中部和东北部运营的研究和创新职能的综合交付系统。他最初于2016年9月加入Geisinger,担任执行副总裁兼首席医疗官,致力于提高整个企业提供的护理的质量、负担能力和体验。Ryu博士此前担任哈门那综合护理交付总裁,负责哈门那自有和合资的护理交付资产,包括协助附属实践采用人口健康模式的管理服务组织(MSO)。在加入哈门那之前,Ryu博士曾在伊利诺伊大学医院和Health Sciences系统、Kaiser Permanente、医疗保险和医疗补助服务中心担任过各种领导职务,并在退伍军人事务部担任白宫研究员。他还是国际公司McDermott,Will & Emery的执业企业医疗保健律师。Ryu博士还在2018年至2024年期间担任医疗保险支付咨询委员会(MedPAC)的专员。他还是美国国家质量保证委员会(NCQA)、英联邦基金以及泰利福公司(NYSE:TFX)的董事。Ryu博士在耶鲁大学获得学士学位,在芝加哥大学获得医学博士和法学博士学位。他在Harbor UCLA医疗中心完成了急诊医学的住院医师培训。


Jaewon Ryu has been the Chief Executive Officer of Risant Health since April 2024 when it acquired Geisinger. Previously, he served as the President and Chief Executive Officer of Geisinger since June 2019, an integrated delivery system with a clinical enterprise, a health plan, the Geisinger Commonwealth School of Medicine, and research and innovation functions operating in central and northeastern Pennsylvania. He originally joined Geisinger in September 2016, as the Executive Vice President and Chief Medical Officer, working to improve the quality, affordability and experience of care delivered across the enterprise. Dr. Ryu was previously President of integrated care delivery for Humana, responsible for Humana's owned and joint ventured care delivery assets, including a management services organization (MSO) assisting affiliated practices to adopt a population health model. Prior to Humana, Dr. Ryu held various leadership roles at the University of Illinois Hospital & Health Sciences System, Kaiser Permanente, the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney with the international firm McDermott, Will & Emery. Dr. Ryu also served from 2018 to 2024 as a commissioner on the Medicare Payment Advisory Commission (MedPAC). He is also a director on the National Committee for Quality Assurance (NCQA), the Commonwealth Fund, and Teleflex, Inc. (NYSE: TFX). Dr. Ryu earned his bachelor's degree from Yale University and his M.D. and J.D. from the University of Chicago. He completed his residency training in emergency medicine at Harbor UCLA Medical Center.
自2024年4月收购Geisinger以来,Jaewon Ryu一直担任Risant Health的首席执行官。此前,他自2019年6月起担任Geisinger的总裁兼首席执行官,Geisinger是一家与临床企业、健康计划、Geisinger联邦医学院以及在宾夕法尼亚州中部和东北部运营的研究和创新职能的综合交付系统。他最初于2016年9月加入Geisinger,担任执行副总裁兼首席医疗官,致力于提高整个企业提供的护理的质量、负担能力和体验。Ryu博士此前担任哈门那综合护理交付总裁,负责哈门那自有和合资的护理交付资产,包括协助附属实践采用人口健康模式的管理服务组织(MSO)。在加入哈门那之前,Ryu博士曾在伊利诺伊大学医院和Health Sciences系统、Kaiser Permanente、医疗保险和医疗补助服务中心担任过各种领导职务,并在退伍军人事务部担任白宫研究员。他还是国际公司McDermott,Will & Emery的执业企业医疗保健律师。Ryu博士还在2018年至2024年期间担任医疗保险支付咨询委员会(MedPAC)的专员。他还是美国国家质量保证委员会(NCQA)、英联邦基金以及泰利福公司(NYSE:TFX)的董事。Ryu博士在耶鲁大学获得学士学位,在芝加哥大学获得医学博士和法学博士学位。他在Harbor UCLA医疗中心完成了急诊医学的住院医师培训。
Jaewon Ryu has been the Chief Executive Officer of Risant Health since April 2024 when it acquired Geisinger. Previously, he served as the President and Chief Executive Officer of Geisinger since June 2019, an integrated delivery system with a clinical enterprise, a health plan, the Geisinger Commonwealth School of Medicine, and research and innovation functions operating in central and northeastern Pennsylvania. He originally joined Geisinger in September 2016, as the Executive Vice President and Chief Medical Officer, working to improve the quality, affordability and experience of care delivered across the enterprise. Dr. Ryu was previously President of integrated care delivery for Humana, responsible for Humana's owned and joint ventured care delivery assets, including a management services organization (MSO) assisting affiliated practices to adopt a population health model. Prior to Humana, Dr. Ryu held various leadership roles at the University of Illinois Hospital & Health Sciences System, Kaiser Permanente, the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney with the international firm McDermott, Will & Emery. Dr. Ryu also served from 2018 to 2024 as a commissioner on the Medicare Payment Advisory Commission (MedPAC). He is also a director on the National Committee for Quality Assurance (NCQA), the Commonwealth Fund, and Teleflex, Inc. (NYSE: TFX). Dr. Ryu earned his bachelor's degree from Yale University and his M.D. and J.D. from the University of Chicago. He completed his residency training in emergency medicine at Harbor UCLA Medical Center.
Francis Soistman

Francis Soistman于2021年11月起担任e Health,Inc.(纳斯达克:EHTH)的首席执行官,直至2025年底退休。Soistman先生还担任e Health董事会成员,自2021年11月起担任该董事会董事。在加入e健康之前,Soistman先生于2020年1月至2021年11月期间创立并担任Healthcare Management and Transformation Advisory Services LLC的总裁,该公司是一家在医疗保健领域运营的咨询服务公司。2013年1月至2019年9月,Soistman先生担任健康解决方案公司西维斯健康的执行副总裁,以及管理式医疗公司安泰保险的政府服务总裁。在任职于安泰集团之前,Soistman Co先生创立了Jessamine Healthcare,此前曾在多家医疗保健和管理式护理公司担任行政领导职务,其中包括Coventry Healthcare、Principal Health Care和Blue Cross Blue Shield of Maryland。Soistman先生拥有陶森大学会计和金融学士学位,毕业于斯坦福大学高管课程。


Francis Soistman served as the Chief Executive Officer of e Health, Inc. (Nasdaq: EHTH) from November 2021 until his retirement in late 2025. Mr. Soistman also serves as member of the e Health board of directors, where he has been a director since November 2021. Prior to e Health, Mr. Soistman founded and served as president of Healthcare Management and Transformation Advisory Services LLC, an advisory services company operating in the healthcare space, from January 2020 to November 2021. From January 2013 to September 2019, Mr. Soistman was executive vice president at CVS Health, a health solutions company, and president of government services at Aetna, a managed care company. Prior to his tenure at Aetna, Mr. Soistman co founded Jessamine Healthcare, having previously served in executive leadership across a number of healthcare and managed care companies, including Coventry Healthcare, Principal Health Care and Blue Cross Blue Shield of Maryland. Mr. Soistman holds a B.S. in accounting and finance from Towson University and is a graduate of the Stanford University executive program.
Francis Soistman于2021年11月起担任e Health,Inc.(纳斯达克:EHTH)的首席执行官,直至2025年底退休。Soistman先生还担任e Health董事会成员,自2021年11月起担任该董事会董事。在加入e健康之前,Soistman先生于2020年1月至2021年11月期间创立并担任Healthcare Management and Transformation Advisory Services LLC的总裁,该公司是一家在医疗保健领域运营的咨询服务公司。2013年1月至2019年9月,Soistman先生担任健康解决方案公司西维斯健康的执行副总裁,以及管理式医疗公司安泰保险的政府服务总裁。在任职于安泰集团之前,Soistman Co先生创立了Jessamine Healthcare,此前曾在多家医疗保健和管理式护理公司担任行政领导职务,其中包括Coventry Healthcare、Principal Health Care和Blue Cross Blue Shield of Maryland。Soistman先生拥有陶森大学会计和金融学士学位,毕业于斯坦福大学高管课程。
Francis Soistman served as the Chief Executive Officer of e Health, Inc. (Nasdaq: EHTH) from November 2021 until his retirement in late 2025. Mr. Soistman also serves as member of the e Health board of directors, where he has been a director since November 2021. Prior to e Health, Mr. Soistman founded and served as president of Healthcare Management and Transformation Advisory Services LLC, an advisory services company operating in the healthcare space, from January 2020 to November 2021. From January 2013 to September 2019, Mr. Soistman was executive vice president at CVS Health, a health solutions company, and president of government services at Aetna, a managed care company. Prior to his tenure at Aetna, Mr. Soistman co founded Jessamine Healthcare, having previously served in executive leadership across a number of healthcare and managed care companies, including Coventry Healthcare, Principal Health Care and Blue Cross Blue Shield of Maryland. Mr. Soistman holds a B.S. in accounting and finance from Towson University and is a graduate of the Stanford University executive program.

高管简历

中英对照 |  中文 |  英文
Parth Mehrotra

Parth Mehrotra自2018年以来一直担任我们的总裁兼首席运营官。在Privia Health任职之前,Mehrotra先生于2016年至2018年担任Privia Health母公司Brighton Health Group Holdings,LLC的首席运营官。2016年之前,Mehrotra先生曾在AthenaHealth Inc.担任高级财务职位,也曾在高盛(Goldman Sachs and Co.)的梦百合投资银行集团工作,并担任埃森哲(Accenture)的管理顾问。Mehrotra先生在西北大学凯洛格管理学院(Northwestern University&8217;s Kellogg School of Management)获得工商管理硕士学位,并在德里大学圣斯蒂芬学院(St.Stephen&8217;s College)获得经济学学士学位。


Parth Mehrotra has served as the Chief Executive Officer of Privia Health since July 2023. Prior to that, he served as Privia Health Group, Inc.'s President and Chief Operating Officer from 2018 to 2023. Prior to his role at Privia Health, from 2016 to 2018, Mr. Mehrotra was the Chief Operating Officer of Brighton Health Group Holdings, LLC, the parent company of Privia Health. Prior to 2016, Mr. Mehrotra held a senior finance role at athenahealth Inc., and also worked in the healthcare investment banking group at Goldman Sachs and Co. and as a management consultant at Accenture. Mr. Mehrotra received an M.B.A. from Northwestern University's Kellogg School of Management and a bachelor's degree in Economics from St. Stephen's College, University of Delhi.
Parth Mehrotra自2018年以来一直担任我们的总裁兼首席运营官。在Privia Health任职之前,Mehrotra先生于2016年至2018年担任Privia Health母公司Brighton Health Group Holdings,LLC的首席运营官。2016年之前,Mehrotra先生曾在AthenaHealth Inc.担任高级财务职位,也曾在高盛(Goldman Sachs and Co.)的梦百合投资银行集团工作,并担任埃森哲(Accenture)的管理顾问。Mehrotra先生在西北大学凯洛格管理学院(Northwestern University&8217;s Kellogg School of Management)获得工商管理硕士学位,并在德里大学圣斯蒂芬学院(St.Stephen&8217;s College)获得经济学学士学位。
Parth Mehrotra has served as the Chief Executive Officer of Privia Health since July 2023. Prior to that, he served as Privia Health Group, Inc.'s President and Chief Operating Officer from 2018 to 2023. Prior to his role at Privia Health, from 2016 to 2018, Mr. Mehrotra was the Chief Operating Officer of Brighton Health Group Holdings, LLC, the parent company of Privia Health. Prior to 2016, Mr. Mehrotra held a senior finance role at athenahealth Inc., and also worked in the healthcare investment banking group at Goldman Sachs and Co. and as a management consultant at Accenture. Mr. Mehrotra received an M.B.A. from Northwestern University's Kellogg School of Management and a bachelor's degree in Economics from St. Stephen's College, University of Delhi.
David Mountcastle

David Mountcastle自2014年以来一直担任我们的首席财务官。在Privia Health任职之前,Mountcastle先生是Brainware Inc.的首席财务官,在iDirect,Inc.担任多个高级财务职位,是Coventry的区域首席财务官,并在United梦百合担任多个高级区域财务职位。Mountcastle先生在安永会计师事务所(Ernst&Young)的创业服务部开始了他的职业生涯。Mountcastle先生在弗吉尼亚联邦大学(Virginia Commonwealth University)获得金融与信息系统双学位的工商管理硕士学位,并在詹姆斯麦迪逊大学(James Madison University)获得会计信息系统学士学位。Mountcastle先生从1992年开始一直担任注册会计师。


David Mountcastle joined Privia Health in June 2014 as VP of Finance, served as Privia Health Group, Inc.'s Chief Financial Officer from June 2016 through January 2022 and resumed this office as of March 2022. Prior to his role at Privia Health, Mr. Mountcastle was the Chief Financial Officer at Brainware Inc., held multiple senior finance roles at iDirect, Inc., was a regional Chief Financial Officer for Coventry and held multiple senior regional finance roles with United Healthcare. Mr. Mountcastle started his career with Ernst & Young in their Entrepreneurial Services Division. Mr. Mountcastle received an M.B.A. with dual concentration in Finance and Information Systems from Virginia Commonwealth University and a BBA in Accounting Information Systems from James Madison University. Mr. Mountcastle has been a CPA since 1992.
David Mountcastle自2014年以来一直担任我们的首席财务官。在Privia Health任职之前,Mountcastle先生是Brainware Inc.的首席财务官,在iDirect,Inc.担任多个高级财务职位,是Coventry的区域首席财务官,并在United梦百合担任多个高级区域财务职位。Mountcastle先生在安永会计师事务所(Ernst&Young)的创业服务部开始了他的职业生涯。Mountcastle先生在弗吉尼亚联邦大学(Virginia Commonwealth University)获得金融与信息系统双学位的工商管理硕士学位,并在詹姆斯麦迪逊大学(James Madison University)获得会计信息系统学士学位。Mountcastle先生从1992年开始一直担任注册会计师。
David Mountcastle joined Privia Health in June 2014 as VP of Finance, served as Privia Health Group, Inc.'s Chief Financial Officer from June 2016 through January 2022 and resumed this office as of March 2022. Prior to his role at Privia Health, Mr. Mountcastle was the Chief Financial Officer at Brainware Inc., held multiple senior finance roles at iDirect, Inc., was a regional Chief Financial Officer for Coventry and held multiple senior regional finance roles with United Healthcare. Mr. Mountcastle started his career with Ernst & Young in their Entrepreneurial Services Division. Mr. Mountcastle received an M.B.A. with dual concentration in Finance and Information Systems from Virginia Commonwealth University and a BBA in Accounting Information Systems from James Madison University. Mr. Mountcastle has been a CPA since 1992.
Edward C. Fargis

Edward C. Fargis被任命为公司秘书兼执行副总裁兼总法律顾问,任期自2024年1月29日起生效。Fargis先生最近担任市场领先的医疗保健技术公司Zelis Parent,L.P.的企业战略交易执行副总裁,此前曾在2017年9月至2022年1月期间担任Zelis的执行副总裁、总法律顾问、首席合规官和公司秘书。在加入Zelis之前,Fargis先生曾担任Personal Touch Home Health,Inc.的总法律顾问、秘书和首席合规官。Fargis先生还曾在2009年11月至2016年12月期间担任Touchstone Health Partnership,Inc.的多个行政和其他高级领导职位,包括首席执行官、总法律顾问、秘书和首席合规官的角色。Fargis先生的法律生涯始于Battle Fowler LLP。他在福特汉姆大学法学院获得法学博士学位,在汉密尔顿学院获得历史学学士学位。


Edward C. Fargis was appointed as the Company's Secretary and Executive Vice President and General Counsel with employment beginning effective January 29, 2024. Mr. Fargis was most recently Executive Vice President, Corporate Strategic Transactions, for Zelis Parent, L.P., a market leading healthcare technology company, and previously held the roles of Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary for Zelis between September 2017 and January 2022. Prior to joining Zelis, Mr. Fargis served as General Counsel, Secretary and Chief Compliance Officer for Personal Touch Home Health, Inc. Mr. Fargis also held various executive and other senior leadership positions for Touchstone Health Partnership, Inc. from November 2009 to December 2016, including the roles of Chief Executive Officer, General Counsel, Secretary and Chief Compliance Officer. Mr. Fargis began his legal career with Battle Fowler LLP. He received a J.D. from Fordham University School of Law and a B.A. in History from Hamilton College.
Edward C. Fargis被任命为公司秘书兼执行副总裁兼总法律顾问,任期自2024年1月29日起生效。Fargis先生最近担任市场领先的医疗保健技术公司Zelis Parent,L.P.的企业战略交易执行副总裁,此前曾在2017年9月至2022年1月期间担任Zelis的执行副总裁、总法律顾问、首席合规官和公司秘书。在加入Zelis之前,Fargis先生曾担任Personal Touch Home Health,Inc.的总法律顾问、秘书和首席合规官。Fargis先生还曾在2009年11月至2016年12月期间担任Touchstone Health Partnership,Inc.的多个行政和其他高级领导职位,包括首席执行官、总法律顾问、秘书和首席合规官的角色。Fargis先生的法律生涯始于Battle Fowler LLP。他在福特汉姆大学法学院获得法学博士学位,在汉密尔顿学院获得历史学学士学位。
Edward C. Fargis was appointed as the Company's Secretary and Executive Vice President and General Counsel with employment beginning effective January 29, 2024. Mr. Fargis was most recently Executive Vice President, Corporate Strategic Transactions, for Zelis Parent, L.P., a market leading healthcare technology company, and previously held the roles of Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary for Zelis between September 2017 and January 2022. Prior to joining Zelis, Mr. Fargis served as General Counsel, Secretary and Chief Compliance Officer for Personal Touch Home Health, Inc. Mr. Fargis also held various executive and other senior leadership positions for Touchstone Health Partnership, Inc. from November 2009 to December 2016, including the roles of Chief Executive Officer, General Counsel, Secretary and Chief Compliance Officer. Mr. Fargis began his legal career with Battle Fowler LLP. He received a J.D. from Fordham University School of Law and a B.A. in History from Hamilton College.